Pathway,Score
Signaling by VEGF,0.04470820336446887
Negative regulation of the PI3K/AKT network,0.002894945922565129
PI3K/AKT Signaling in Cancer,0.10783062250958375
G beta:gamma signalling through PI3Kgamma,0.04827046850357243
G-protein beta:gamma signalling,-0.006610470535841803
VEGFA-VEGFR2 Pathway,0.0004760681662521685
VEGFR2 mediated vascular permeability,0.009399010314216071
Constitutive Signaling by AKT1 E17K in Cancer,0.07818638404787859
Respiratory Syncytial Virus Infection Pathway,0.07019056613385957
RSV-host interactions,0.04026978791754701
RHO GTPases Activate WASPs and WAVEs,-0.011162231762782152
RAC2 GTPase cycle,0.04620732391343993
RAC3 GTPase cycle,-0.04798957115071288
Parasite infection,0.09301795683286847
Leishmania phagocytosis,-0.004156623813436534
FCGR3A-mediated phagocytosis,0.017349454865460124
Signaling by NOTCH1,-0.0193376578790889
NOTCH1 Intracellular Domain Regulates Transcription,-0.020470187245554865
Signaling by NOTCH1 PEST Domain Mutants in Cancer,0.040940216714896234
Signaling by NOTCH1 in Cancer,0.023552823557594863
Constitutive Signaling by NOTCH1 PEST Domain Mutants,-0.04464341389674484
Signaling by NOTCH1 HD+PEST Domain Mutants in Cancer,-0.04866674475442172
Constitutive Signaling by NOTCH1 HD+PEST Domain Mutants,-0.008323049573232584
Regulation of PTEN gene transcription,0.01620385633578771
Budding and maturation of HIV virion,0.07691823972661643
Uptake and actions of bacterial toxins,0.014156325041573081
Bacterial Infection Pathways,-0.038789138893637345
NRAGE signals death through JNK,-0.0031300626046158087
p75 NTR receptor-mediated signalling,-0.0104398834021292
"Cell death signalling via NRAGE, NRIF and NADE",0.0662779936284586
Deregulated CDK5 triggers multiple neurodegenerative pathways in Alzheimer's disease models,0.0020185771445630375
Neurodegenerative Diseases,0.04480539198889063
Diseases of programmed cell death,0.07948326820270779
Defective Intrinsic Pathway for Apoptosis,-0.0010206274333948392
Signaling by SCF-KIT,-0.012128163210106683
Regulation of KIT signaling,0.025444217945672334
Degradation of beta-catenin by the destruction complex,-0.022677407993822923
Beta-catenin phosphorylation cascade,0.021042202337059935
Disassembly of the destruction complex and recruitment of AXIN to the membrane,-0.010412009500525095
G alpha (12/13) signalling events,0.10601726347136706
Pre-NOTCH Transcription and Translation,-0.05431090890582171
Pre-NOTCH Expression and Processing,-0.05680995880508422
Signaling by NOTCH2,-0.051403970570617505
NOTCH2 intracellular domain regulates transcription,-0.060936278702967334
Signaling by NOTCH3,0.009689639694340729
NOTCH3 Intracellular Domain Regulates Transcription,-0.025239128909381018
Signaling by NOTCH4,-0.010645402727816285
NOTCH4 Intracellular Domain Regulates Transcription,-0.011536152624655273
Signaling by MET,0.04063628410941171
RAS processing,0.01788480893587682
Potential therapeutics for SARS,-0.03970805435466083
Host Interactions of HIV factors,-0.09255344494592684
Nef-mediates down modulation of cell surface receptors by recruiting them to clathrin adapters,0.02469163066018381
The role of Nef in HIV-1 replication and disease pathogenesis,0.00730678318196657
NR1H2 and NR1H3-mediated signaling,0.010451369174563968
NR1H3 & NR1H2 regulate gene expression linked to cholesterol transport and efflux,0.08717215553158322
Diseases of glycosylation,0.027049153598780292
Diseases associated with O-glycosylation of proteins,0.005573965460004146
Defective GALNT3 causes HFTC,-0.014181346798722478
Defective GALNT12 causes CRCS1,0.01156338268145493
Diseases of metabolism,0.021906839043117007
Diseases of DNA repair,0.03237799838913037
Diseases of DNA Double-Strand Break Repair,-0.020172485612127127
Defective homologous recombination repair (HRR) due to BRCA2 loss of function,-0.020451594692550066
Defective homologous recombination repair (HRR) due to BRCA1 loss of function,-0.006902051132894499
Defective homologous recombination repair (HRR) due to PALB2 loss of function,-0.014787461096445593
Defective HDR through Homologous Recombination Repair (HRR) due to PALB2 loss of BRCA1 binding function,0.006320293539103058
Defective HDR through Homologous Recombination Repair (HRR) due to PALB2 loss of BRCA2/RAD51/RAD51C binding function,-0.00427964412458466
Impaired BRCA2 binding to RAD51,0.019966135522907248
Impaired BRCA2 binding to PALB2,0.019419049568852043
Effects of PIP2 hydrolysis,-0.042489434503908775
Integrin signaling,-0.004979675758977863
Retrograde neurotrophin signalling,6.248873137029168e-05
Signaling by NTRK1 (TRKA),-0.09642145762283136
TNFR1-induced proapoptotic signaling,-0.019717595106830094
Regulation of TNFR1 signaling,-0.05265853761991416
TNFR1-induced NF-kappa-B signaling pathway,0.10756279063808355
TNF signaling,0.0291826279109333
RHOA GTPase cycle,0.07739500769748696
SARS-CoV-2 activates/modulates innate and adaptive immune responses,0.06752191233478558
HCMV Infection,0.013613920156179996
HCMV Early Events,-0.008367637476745597
Regulation of RAS by GAPs,-0.06065172913709044
RHOF GTPase cycle,-0.03436696221648759
P2Y receptors,-0.005241851944442768
Nucleotide-like (purinergic) receptors,0.0030035864133959294
Signaling by PTK6,-0.021483758467362998
Signaling by Non-Receptor Tyrosine Kinases,0.023461003066532104
Signaling by Retinoic Acid,-0.03800617721439455
RA biosynthesis pathway,-0.03474878769702227
Signaling by ERBB2,-0.004789737013651545
Downregulation of ERBB2 signaling,0.021860201868834868
Activated NOTCH1 Transmits Signal to the Nucleus,-0.00035552202263465824
NOTCH2 Activation and Transmission of Signal to the Nucleus,0.09580851125678437
NOTCH3 Activation and Transmission of Signal to the Nucleus,0.034587636196723136
Opioid Signalling,-0.04515948610182222
DARPP-32 events,0.044285770828438806
Nuclear Events (kinase and transcription factor activation),-0.014019040504204895
Signaling by NTRK2 (TRKB),-0.0308801369609126
NGF-stimulated transcription,-0.00793350647912736
Class B/2 (Secretin family receptors),0.027351041029154657
G alpha (s) signalling events,-0.06901993989488617
RHOB GTPase cycle,-0.011653329496330647
RHOC GTPase cycle,-0.01355514215225458
Vpu mediated degradation of CD4,0.006482871426826444
Vif-mediated degradation of APOBEC3G,-0.029507637485493367
PCP/CE pathway,-0.05271473267968131
Asymmetric localization of PCP proteins,0.03850632473136492
Degradation of AXIN,0.040631240526515434
Degradation of DVL,0.0028360536661138445
Hedgehog ligand biogenesis,-0.04133620527200667
Hh mutants are degraded by ERAD,-0.010146662435247962
Hh mutants abrogate ligand secretion,0.021433513064414864
Degradation of GLI1 by the proteasome,-0.0035160939430952613
Degradation of GLI2 by the proteasome,-0.04078510228255699
GLI3 is processed to GLI3R by the proteasome,-0.025583986495939598
Hedgehog 'off' state,-0.010563077297044315
ABC transporter disorders,0.005074490754565308
Disorders of transmembrane transporters,0.005687140666180054
Hedgehog 'on' state,0.14472794585188647
Defective CFTR causes cystic fibrosis,0.07030876038181479
MAPK6/MAPK4 signaling,0.03823340228886362
Regulation of PTEN stability and activity,-0.013057644878538409
Negative regulation of NOTCH4 signaling,0.005373166173810226
Formation of HIV elongation complex in the absence of HIV Tat,-0.013235440005181945
Formation of the HIV-1 Early Elongation Complex,-0.014035228118753058
RNA Pol II CTD phosphorylation and interaction with CE during HIV infection,-0.019688886365863998
HIV Transcription Initiation,0.007327563428537751
RNA Polymerase II HIV Promoter Escape,-0.012428436518290446
HIV Transcription Elongation,-0.04121906110320064
Transcription of the HIV genome,0.0360469879445113
Formation of HIV-1 elongation complex containing HIV-1 Tat,-0.018832810320887263
Tat-mediated elongation of the HIV-1 transcript,-0.03729564456944312
RHOBTB3 ATPase cycle,0.019801725091681356
Signaling by TGF-beta Receptor Complex,0.0935699352432517
Transcriptional activity of SMAD2/SMAD3:SMAD4 heterotrimer,-0.02989388089482577
SMAD2/SMAD3:SMAD4 heterotrimer regulates transcription,-0.03644028448496262
Pausing and recovery of Tat-mediated HIV elongation,-0.0019429746807413638
Tat-mediated HIV elongation arrest and recovery,-0.035984795101977614
HIV elongation arrest and recovery,0.019070516631291282
Pausing and recovery of HIV elongation,-0.022645944085540017
Estrogen-dependent gene expression,0.010211747347020423
RHOBTB2 GTPase cycle,0.0601379343526061
RHOBTB1 GTPase cycle,0.028919077878035257
RHOBTB GTPase Cycle,-0.06362986641236777
Signaling by EGFR,0.006723789355390386
EGFR downregulation,-0.004828171032019745
Signaling by FGFR,0.12318594799600066
Negative regulation of FGFR1 signaling,0.003985324824845397
Negative regulation of FGFR2 signaling,-0.0018809991320456047
Negative regulation of FGFR3 signaling,-0.009712720200032993
Negative regulation of FGFR4 signaling,0.04697786729323057
Signaling by FGFR1,0.03454156725155865
Signaling by FGFR2,0.017889810445601364
Signaling by FGFR3,-0.02746049326214172
Signaling by FGFR4,0.019986809992860753
Negative regulation of MET activity,-0.015067513143034674
InlB-mediated entry of Listeria monocytogenes into host cell,0.038144379653858064
Listeria monocytogenes entry into host cells,0.011706702150627685
RHOU GTPase cycle,0.012475554675722223
MAP2K and MAPK activation,0.028856106367883744
Signaling by moderate kinase activity BRAF mutants,0.03437901040963736
Signaling by high-kinase activity BRAF mutants,0.013897555084755858
Signaling by RAS mutants,0.0017658476502616853
Signaling by BRAF and RAF1 fusions,-0.03497713078410827
Paradoxical activation of RAF signaling by kinase inactive BRAF,0.015582472401750215
Oncogenic MAPK signaling,-0.020271812386302594
Signaling downstream of RAS mutants,0.006515952579430946
Signaling by RAF1 mutants,0.035966796630451804
AKT phosphorylates targets in the cytosol,-0.009581734755812553
Aberrant regulation of mitotic G1/S transition in cancer due to RB1 defects,0.006014877409142714
"Defective binding of RB1 mutants to E2F1,(E2F2, E2F3)",0.041843925192442316
Diseases of mitotic cell cycle,-0.004234940587625607
FLT3 signaling in disease,-0.012867109824148954
Aberrant regulation of mitotic cell cycle due to RB1 defects,0.01187894299160895
Signaling by ALK in cancer,-0.09754047890755421
Signaling by FLT3 ITD and TKD mutants,-0.009941536985847392
Signaling by ALK fusions and activated point mutants,-0.059892001482063986
RHO GTPases activate CIT,0.038745101074905995
Extra-nuclear estrogen signaling,0.008770584743300745
Estrogen-dependent nuclear events downstream of ESR-membrane signaling,0.004231009505740014
Signaling by Activin,0.010520091214892828
Downregulation of TGF-beta receptor signaling,-0.02151878919300407
TGF-beta receptor signaling activates SMADs,0.046625751471662286
G alpha (z) signalling events,-0.03985196126929841
Activation of RAC1,-8.430497647038263e-05
RHOQ GTPase cycle,-0.07664797201567262
RHOH GTPase cycle,-0.01719090167606475
RHOG GTPase cycle,-0.013838708347850693
RHOJ GTPase cycle,0.07909331509746087
RHOV GTPase cycle,-0.01336862511063841
Signaling by Insulin receptor,0.021201707417244756
Insulin receptor recycling,0.04228809650315585
MET activates PTK2 signaling,0.0001169660045906593
MET promotes cell motility,-0.07947039638947104
MTOR signalling,0.004033361037128953
mTORC1-mediated signalling,0.00223534873438051
Energy dependent regulation of mTOR by LKB1-AMPK,0.007031997856949212
Diseases of Immune System,0.02241538998864817
Diseases associated with the TLR signaling cascade,-0.01483856160411997
RHO GTPases activate IQGAPs,-0.020331703325058743
RHO GTPases Activate Formins,0.04715637487143899
RHO GTPases activate PKNs,-0.03511421444269751
RHO GTPases Activate ROCKs,-0.016709437088648218
RHO GTPases activate PAKs,-0.021090805200797248
Aberrant regulation of mitotic exit in cancer due to RB1 defects,0.033047840045208665
Pre-NOTCH Processing in Golgi,0.01486051576577322
Signaling by ERBB4,-0.009095599066780546
Nuclear signaling by ERBB4,0.014877580086039269
Signaling by Hippo,0.037843314996456885
RHOD GTPase cycle,-0.010285968288306944
SARS-CoV-1-host interactions,-0.07984374951498437
SARS-CoV-1 activates/modulates innate immune responses,-0.016048834220917303
RND3 GTPase cycle,0.04376901373093326
Nuclear events stimulated by ALK signaling in cancer,-0.014442349810407179
HCMV Late Events,-0.03722971927774395
Formation of the beta-catenin:TCF transactivating complex,0.05693575585321162
Peptide ligand-binding receptors,-0.021014050179446096
Chemokine receptors bind chemokines,0.014194635780354644
Translation of Structural Proteins,0.002691544503198113
Maturation of spike protein,0.00715967486070358
Late SARS-CoV-2 Infection Events,-0.09081532520653193
Purinergic signaling in leishmaniasis infection,0.0005375432783398311
Cell recruitment (pro-inflammatory response),0.05071244160311964
CaMK IV-mediated phosphorylation of CREB,0.0009906470918501808
Calmodulin induced events,-0.00235633671352001
Ca-dependent events,0.031151097829256343
CaM pathway,-0.010902407011671568
G-protein mediated events,0.009083330744605135
PLC beta mediated events,-0.036029060391825504
DAG and IP3 signaling,0.0034464755319532294
G-protein activation,-0.0037089813181392798
Ca2+ pathway,-0.041507387081770535
G beta:gamma signalling through PLC beta,-0.0030260777392542007
Glucagon-type ligand receptors,0.08663030163342104
G beta:gamma signalling through BTK,-0.02999104394019711
G beta:gamma signalling through CDC42,-0.02017362463392523
GPER1 signaling,0.010933529941624229
ADORA2B mediated anti-inflammatory cytokines production,-0.01624694685291697
Anti-inflammatory response favouring Leishmania parasite infection,-0.007310667399549494
Leishmania parasite growth and survival,-0.021264267044047897
PKA-mediated phosphorylation of CREB,-0.018936445515241283
PKA activation,0.010300476964350918
Adenylate cyclase activating pathway,0.0022639794495714883
Adenylate cyclase inhibitory pathway,-0.011063527093977319
FCGR3A-mediated IL10 synthesis,-0.007399695252891519
Signaling by ERBB2 in Cancer,0.0167518774084283
Constitutive Signaling by Aberrant PI3K in Cancer,0.01352696982033113
"PI5P, PP2A and IER3 Regulate PI3K/AKT Signaling",-0.05696847544024769
Signaling by ERBB2 KD Mutants,-0.0021893840158947243
Signaling by ERBB2 TMD/JMD mutants,-0.00035505209233820237
RND2 GTPase cycle,0.054776481630103735
Signaling by TGFBR3,0.02892949468941891
Rev-mediated nuclear export of HIV RNA,-0.007879542536279672
Transport of Ribonucleoproteins into the Host Nucleus,0.0030478723659127464
Export of Viral Ribonucleoproteins from Nucleus,-0.020926977066020282
NS1 Mediated Effects on Host Pathways,-0.018569907010685106
Viral Messenger RNA Synthesis,0.02670742838515244
NEP/NS2 Interacts with the Cellular Export Machinery,-0.016202839231716698
Interactions of Vpr with host cellular proteins,0.06313121281875764
Interactions of Rev with host cellular proteins,-0.005589965811498286
Nuclear import of Rev protein,-0.06367741895607265
Vpr-mediated nuclear import of PICs,0.00238102822220612
SLC transporter disorders,-0.03569808348381785
Defective TPR may confer susceptibility towards thyroid papillary carcinoma (TPC),-0.013017829387941144
VEGFR2 mediated cell proliferation,0.0028656915181096945
Eicosanoid ligand-binding receptors,-0.03318261872835681
RHO GTPases Activate NADPH Oxidases,0.0003195669165921441
Downstream signaling of activated FGFR1,-0.01336589107520795
FRS-mediated FGFR1 signaling,-0.00416388593537201
Downstream signaling of activated FGFR2,0.007485438397224416
FRS-mediated FGFR2 signaling,0.00466943614594034
FRS-mediated FGFR3 signaling,0.001324892208812256
Downstream signaling of activated FGFR3,-0.05399575531512191
FRS-mediated FGFR4 signaling,-0.00922259574967672
Downstream signaling of activated FGFR4,-0.015419264582521937
RND1 GTPase cycle,-0.06732265365927632
Signaling by FGFR in disease,0.004925822853910428
Prolonged ERK activation events,0.00028338822715501553
Frs2-mediated activation,0.00022182932017240974
Signalling to ERKs,-0.09244094004482811
Signaling by ALK,-0.021352567275165726
Signaling by FGFR2 in disease,-0.04819449081015921
Signaling by FGFR1 in disease,-0.021938106430858525
Signaling by FGFR3 in disease,0.007338394514764482
SARS-CoV-1 targets host intracellular signalling and regulatory pathways,0.0018118193964308685
Activation of SMO,-0.0011184698829658252
Constitutive Signaling by Ligand-Responsive EGFR Cancer Variants,0.01604390468024811
Signaling by EGFR in Cancer,0.004597544298955922
Constitutive Signaling by EGFRvIII,-0.005729477161612348
Signaling by EGFRvIII in Cancer,0.012843308098530473
Signaling by Ligand-Responsive EGFR Variants in Cancer,0.027668983484618877
Signaling by ERBB2 ECD mutants,0.021599639959948132
Infection with Mycobacterium tuberculosis,0.005654271642719898
Response of Mtb to phagocytosis,-0.010818827884556983
Signaling by BMP,-0.015835527995412796
Early Phase of HIV Life Cycle,-0.012550998686661922
SARS-CoV-2 modulates host translation machinery,-0.008482384385360437
RAF-independent MAPK1/3 activation,-0.005633034053596346
Negative regulation of MAPK pathway,0.00981998131693815
Viral mRNA Translation,-0.022962851289747205
Amine ligand-binding receptors,-0.0168967582929441
Neurotoxicity of clostridium toxins,0.019802849737446646
SARS-CoV-2 modulates autophagy,-0.013352611175119558
PI3K Cascade,-0.03892962143000511
IRS-mediated signalling,-0.01595255501583109
Signaling by Type 1 Insulin-like Growth Factor 1 Receptor (IGF1R),0.03960987408107522
IGF1R signaling cascade,-0.04596358307845606
IRS-related events triggered by IGF1R,-0.0011718377654426348
Insulin receptor signalling cascade,-0.016339596821511503
WNT5A-dependent internalization of FZD4,0.020674477419390668
"WNT5A-dependent internalization of FZD2, FZD5 and ROR2",-0.03135394993443417
Induction of Cell-Cell Fusion,-0.027554101659319513
Signaling by PDGF,0.023350316333112933
Translation of Replicase and Assembly of the Replication Transcription Complex,0.026688691470158506
Early SARS-CoV-2 Infection Events,0.03677541089512548
Assembly Of The HIV Virion,-0.02886926871352708
Evasion by RSV of host interferon responses,0.008580116286229872
Downstream signal transduction,0.007096770193665487
p130Cas linkage to MAPK signaling for integrins,-0.02999377322323865
Signaling by Erythropoietin,0.048442235388480734
SARS-CoV-1 modulates host translation machinery,0.003381930637335983
Downregulation of SMAD2/3:SMAD4 transcriptional activity,-0.009863590975252506
Maturation of nucleoprotein,0.00879197688397306
Signalling to RAS,0.008851090083935486
FGFR2 ligand binding and activation,-0.00987299586544548
Signaling by WNT in cancer,-0.016070431044902283
Signaling by AXIN mutants,0.022401162427781524
Signaling by CTNNB1 phospho-site mutants,-0.00545811414994992
Signaling by APC mutants,0.0032443603313980483
Signaling by AMER1 mutants,0.006663808153048775
Signaling by GSK3beta mutants,-0.01545417997319588
CTNNB1 S33 mutants aren't phosphorylated,-0.013724342554545563
CTNNB1 S37 mutants aren't phosphorylated,0.04134922136163206
CTNNB1 S45 mutants aren't phosphorylated,0.0020547903121607503
CTNNB1 T41 mutants aren't phosphorylated,0.012288502000862934
APC truncation mutants have impaired AXIN binding,-0.03459510292981669
AXIN missense mutants destabilize the destruction complex,-0.020679166381916202
Truncations of AMER1 destabilize the destruction complex,-0.00790975604904217
"Respiratory syncytial virus (RSV) genome replication, transcription and translation",0.004311628089481498
Maturation of hRSV A proteins,-0.010822501795042417
RHO GTPases activate KTN1,0.00028557625520106986
Deactivation of the beta-catenin transactivating complex,0.012396756407612647
Repression of WNT target genes,0.013727624145541479
FGFR4 ligand binding and activation,-0.009324933973525814
Phospholipase C-mediated cascade; FGFR4,0.019504390786636166
SHC-mediated cascade:FGFR4,0.029972230126752986
PI-3K cascade:FGFR4,0.04216079425608841
STAT3 nuclear events downstream of ALK signaling,0.011133018532942131
Defective pyroptosis,-0.04456275515617467
ERK/MAPK targets,-0.013060645848883837
ERKs are inactivated,0.017916342869451925
TGFBR3 expression,-0.022223835819222125
Erythropoietin activates Phosphoinositide-3-kinase (PI3K),0.021113146413595917
Class C/3 (Metabotropic glutamate/pheromone receptors),0.08303799879830993
FGFR1 mutant receptor activation,-0.021959468167976042
FGFR2 mutant receptor activation,0.022698670205871727
Activated point mutants of FGFR2,0.02714856100299651
Phospholipase C-mediated cascade; FGFR2,-0.008433822640306452
PI-3K cascade:FGFR1,-0.038057590200122275
PI-3K cascade:FGFR2,-0.016561617183560504
SHC-mediated cascade:FGFR2,0.003046999645995859
Signaling by FGFR2 IIIa TM,-0.009622770274216236
TGF-beta receptor signaling in EMT (epithelial to mesenchymal transition),-0.004625681294816182
Abortive elongation of HIV-1 transcript in the absence of Tat,0.015804574282713483
FGFR2 alternative splicing,0.018487893777139525
Regulation of PTEN mRNA translation,0.051231485922232554
Competing endogenous RNAs (ceRNAs) regulate PTEN translation,0.018082956399212254
NRIF signals cell death from the nucleus,-0.0013683228850551348
Signaling by KIT in disease,-0.028072196965044014
"Signaling by phosphorylated juxtamembrane, extracellular and kinase domain KIT mutants",-0.009517225219388336
Loss of function of MECP2 in Rett syndrome,-0.004895826637128789
Pervasive developmental disorders,-0.001289115225824804
Disorders of Developmental Biology,0.016237078114455232
Disorders of Nervous System Development,0.025358769085156305
Defects in vitamin and cofactor metabolism,-0.006468043899647236
Regulation of FZD by ubiquitination,-0.018762570832142805
Serotonin receptors,-0.0021885285254742795
p75NTR signals via NF-kB,0.030480405163554963
Signaling by NTRK3 (TRKC),-0.0009298085021354735
RAF activation,-0.005927399503864976
p75NTR regulates axonogenesis,-0.009014837985215097
WNT ligand biogenesis and trafficking,-0.014509164208308856
